1. Home
  2. BAH vs RDY Comparison

BAH vs RDY Comparison

Compare BAH & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Booz Allen Hamilton Holding Corporation

BAH

Booz Allen Hamilton Holding Corporation

N/A

Current Price

$70.75

Market Cap

9.6B

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$12.31

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAH
RDY
Founded
1914
1984
Country
United States
India
Employees
31500
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.9B
IPO Year
2010
2001

Fundamental Metrics

Financial Performance
Metric
BAH
RDY
Price
$70.75
$12.31
Analyst Decision
Hold
Hold
Analyst Count
15
5
Target Price
★ $85.23
$13.31
AVG Volume (30 Days)
1.4M
★ 2.5M
Earning Date
10-23-2026
10-23-2026
Dividend Yield
★ 3.40%
0.51%
EPS Growth
N/A
★ N/A
EPS
★ 1.63
N/A
Revenue
★ $11,217,000,000.00
N/A
Revenue This Year
$1.70
$4.73
Revenue Next Year
$4.39
$11.63
P/E Ratio
$42.93
★ $18.67
Revenue Growth
N/A
★ N/A
52 Week Low
$59.50
$11.36
52 Week High
$109.10
$15.67

Technical Indicators

Market Signals
Indicator
BAH
RDY
Relative Strength Index (RSI) 44.81 54.62
Support Level $69.99 $12.09
Resistance Level $80.95 $12.48
Average True Range (ATR) 2.06 0.21
MACD -0.81 0.07
Stochastic Oscillator 26.57 64.87

Price Performance

Historical Comparison
BAH
RDY

About BAH Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: